Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).

IBIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.12%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $39,660.40

iBio Insider Trading History Chart

iBio Share Price & Price History

^$1.99

▼ -0.04 (-1.97%)

As of 05/3/2024 01:00 AM ET

Days: 30 | 90 | 365

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

iBio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2023	Martin Brenner	Insider	Sell	210	$6.20	$1,302.00	9,632
8/28/2023	Martin Brenner	Insider	Sell	250	$6.20	$1,550.00	9,843
7/27/2023	Martin Brenner	Insider	Sell	225	$10.20	$2,295.00	10,093
7/12/2023	Martin Brenner	Insider	Sell	2,351	$11.80	$27,741.80	10,319
6/21/2023	Martin Brenner	Insider	Sell	209	$13.60	$2,842.40	12,670
5/22/2023	Martin Brenner	Insider	Sell	209	$18.80	$3,929.20	12,879
4/24/2023	Martin Brenner	Insider	Sell	219	$24.00	$5,256.00	13,088
3/23/2023	Martin Brenner	Insider	Sell	260	$42.60	$11,076.00	10,807
3/10/2022	Robert Matthew Lutz	Insider	Sell	1,231	$7.00	$8,617.00

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

See why the elites are pouring billions into gold.

SEC Filings (Institutional Ownership Changes) for iBio (NYSEMKT:IBIO)

7.90% of iBio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

iBio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/18/2023	Avantax Planning Partners Inc.	155,000	$95K	0.0%	N/A	0.923%
11/14/2022	Ergoteles LLC	835,436	$0.14M	0.0%	-18.8%	9.275%
5/9/2022	Avantax Planning Partners Inc.	125,000	$54K	0.0%	+400.0%	0.057%
5/2/2022	Allspring Global Investments Holdings LLC	84,301	$36K	0.0%	N/A	0.039%
2/10/2022	Qube Research & Technologies Ltd	217,716	$0.12M	0.0%	N/A	0.100%
2/8/2022	Northern Trust Corp	1,901,858	$1.04M	0.0%	-1.9%	0.873%
2/7/2022	SG Americas Securities LLC	56,192	$31K	0.0%	-58.5%	0.026%
2/1/2022	Qube Research & Technologies Ltd	217,716	$0.12M	0.0%	N/A	0.100%
11/16/2021	Squarepoint Ops LLC	354,145	$0.38M	0.0%	-26.8%	0.162%
11/16/2021	Metropolitan Life Insurance Co NY	62,929	$67K	0.0%	N/A	0.029%
11/15/2021	Man Group plc	207,729	$0.22M	0.0%	+56.5%	0.095%
11/15/2021	Franklin Resources Inc.	70,300	$75K	0.0%	N/A	0.032%
11/12/2021	The Manufacturers Life Insurance Company	146,481	$0.16M	0.0%	+12.0%	0.067%
11/12/2021	Geode Capital Management LLC	4,100,969	$4.35M	0.0%	+14.8%	1.882%
11/10/2021	Goldman Sachs Group Inc.	235,580	$0.25M	0.0%	+165.1%	0.108%
11/10/2021	Citigroup Inc.	47,775	$51K	0.0%	+51.0%	0.022%
11/9/2021	Barclays PLC	88,318	$93K	0.0%	-13.1%	0.041%
11/9/2021	BlackRock Inc.	15,517,020	$16.45M	0.0%	-0.2%	7.119%
11/9/2021	Principal Financial Group Inc.	60,957	$64K	0.0%	-18.5%	0.028%
11/5/2021	AXS Investments LLC	43,832	$46K	0.0%	N/A	0.020%
11/1/2021	SG Americas Securities LLC	135,523	$0.14M	0.0%	N/A	0.062%
8/25/2021	Marshall Wace LLP	170,524	$0.26M	0.0%	N/A	0.078%
8/17/2021	Man Group plc	132,729	$0.20M	0.0%	N/A	0.061%
8/17/2021	Price T Rowe Associates Inc. MD	152,633	$0.23M	0.0%	-18.1%	0.070%
8/16/2021	Squarepoint Ops LLC	483,959	$0.73M	0.0%	N/A	0.222%
8/16/2021	Cubist Systematic Strategies LLC	16,522	$25K	0.0%	-57.4%	0.008%
8/16/2021	California State Teachers Retirement System	297,557	$0.45M	0.0%	-7.8%	0.137%
8/16/2021	Schonfeld Strategic Advisors LLC	37,700	$57K	0.0%	N/A	0.017%
8/16/2021	State Street Corp	3,846,390	$5.81M	0.0%	+31.2%	1.766%
8/16/2021	Nuveen Asset Management LLC	968,383	$1.46M	0.0%	+58.6%	0.445%
8/16/2021	Marshall Wace LLP	170,524	$0.26M	0.0%	N/A	0.078%
8/13/2021	Northern Trust Corp	2,002,295	$3.02M	0.0%	-8.5%	0.919%
8/13/2021	Geode Capital Management LLC	3,572,685	$5.39M	0.0%	+6.6%	1.640%
8/13/2021	Vanguard Group Inc.	10,449,703	$15.78M	0.0%	-1.1%	4.797%
8/12/2021	JPMorgan Chase & Co.	185,760	$0.28M	0.0%	-68.5%	0.085%
8/12/2021	Ergoteles LLC	35,700	$54K	0.0%	N/A	0.016%
8/11/2021	Bank of New York Mellon Corp	610,839	$0.92M	0.0%	+19.5%	0.280%
8/11/2021	BlackRock Inc.	15,553,337	$23.49M	0.0%	+0.8%	7.139%
8/10/2021	Principal Financial Group Inc.	74,803	$0.11M	0.0%	-93.2%	0.034%
8/10/2021	WINTON GROUP Ltd	77,707	$0.12M	0.0%	-25.2%	0.036%
8/9/2021	Belpointe Asset Management LLC	117,750	$0.18M	0.0%	N/A	0.054%
8/5/2021	Rhumbline Advisers	251,990	$0.38M	0.0%	+68.5%	0.116%
8/2/2021	New York State Common Retirement Fund	127,238	$0.19M	0.0%	+7.6%	0.058%
7/30/2021	Alliancebernstein L.P.	135,800	$0.21M	0.0%	+50.4%	0.062%
5/24/2021	Principal Financial Group Inc.	1,106,018	$1.70M	0.0%	+8.1%	0.508%
5/19/2021	Virtu Financial LLC	93,753	$0.14M	0.0%	+69.5%	0.043%
5/18/2021	Millennium Management LLC	183,340	$0.28M	0.0%	+40.2%	0.085%
5/18/2021	Cubist Systematic Strategies LLC	38,802	$60K	0.0%	N/A	0.018%
5/18/2021	California State Teachers Retirement System	322,848	$0.50M	0.0%	+18.5%	0.149%
5/17/2021	AQR Capital Management LLC	132,941	$0.21M	0.0%	-15.8%	0.062%
5/17/2021	Edmond DE Rothschild Holding S.A.	200,000	$0.31M	0.0%	+100.0%	0.093%
5/17/2021	Price T Rowe Associates Inc. MD	186,333	$0.29M	0.0%	-16.4%	0.086%
5/17/2021	Nuveen Asset Management LLC	610,421	$0.94M	0.0%	+12.4%	0.283%
5/17/2021	Atom Investors LP	16,131	$25K	0.0%	-54.1%	0.007%
5/17/2021	Goldman Sachs Group Inc.	82,133	$0.13M	0.0%	+202.3%	0.038%
5/14/2021	First Manhattan Co.	20,790	$32K	0.0%	N/A	0.010%
5/14/2021	XTX Topco Ltd	36,007	$55K	0.0%	N/A	0.017%
5/14/2021	Credit Suisse AG	25,153	$39K	0.0%	-49.9%	0.012%
5/13/2021	SG Americas Securities LLC	48,413	$75K	0.0%	+266.9%	0.022%
5/13/2021	Barclays PLC	253,209	$0.39M	0.0%	+335.4%	0.117%
5/13/2021	Bank of New York Mellon Corp	511,086	$0.79M	0.0%	+19.5%	0.237%
5/12/2021	Northern Trust Corp	2,189,173	$3.37M	0.0%	+12.0%	1.013%
5/12/2021	Geode Capital Management LLC	3,350,551	$5.16M	0.0%	+35.6%	1.551%
5/12/2021	JPMorgan Chase & Co.	590,357	$0.91M	0.0%	+18.5%	0.273%
5/12/2021	UBS Group AG	50,106	$77K	0.0%	+52.3%	0.023%
5/12/2021	InterOcean Capital Group LLC	35,000	$54K	0.0%	+133.3%	0.016%
5/11/2021	New York State Common Retirement Fund	118,200	$0.18M	0.0%	+14.3%	0.055%
5/10/2021	Principal Financial Group Inc.	1,106,018	$1.70M	0.0%	+8.1%	0.512%
5/7/2021	BlackRock Inc.	15,432,756	$23.77M	0.0%	+33.3%	7.144%
5/7/2021	American International Group Inc.	124,749	$0.19M	0.0%	+19.1%	0.058%
5/6/2021	Rhumbline Advisers	149,533	$0.23M	0.0%	+39.6%	0.069%
5/4/2021	Commonwealth Equity Services LLC	50,300	$77K	0.0%	N/A	0.023%
4/12/2021	HighPoint Advisor Group LLC	25,985	$38K	0.0%	-45.5%	0.012%
2/24/2021	Virtu Financial LLC	55,303	$58K	0.0%	-80.7%	0.026%
2/23/2021	Principal Financial Group Inc.	1,023,325	$1.08M	0.0%	N/A	0.474%
2/19/2021	JPMorgan Chase & Co.	498,147	$0.52M	0.0%	+632.1%	0.274%
2/17/2021	Jane Street Group LLC	70,501	$74K	0.0%	N/A	0.039%
2/16/2021	Nuveen Asset Management LLC	542,852	$0.57M	0.0%	+89.8%	0.298%
2/16/2021	Price T Rowe Associates Inc. MD	222,855	$0.23M	0.0%	+108.7%	0.122%
2/16/2021	ETF Managers Group LLC	88,576	$97K	0.0%	-9.5%	0.049%
2/16/2021	Charles Schwab Investment Management Inc.	449,604	$0.47M	0.0%	+131.9%	0.247%
2/13/2021	American International Group Inc.	104,712	$0.11M	0.0%	+203.5%	0.057%
2/12/2021	Amalgamated Bank	24,331	$26K	0.0%	N/A	0.013%
2/12/2021	The Manufacturers Life Insurance Company	120,326	$0.13M	0.0%	+276.7%	0.066%
2/12/2021	Credit Suisse AG	50,211	$52K	0.0%	N/A	0.028%
2/11/2021	Arcus Capital Partners LLC	43,832	$46K	0.0%	N/A	0.024%
2/11/2021	Northern Trust Corp	1,954,299	$2.05M	0.0%	+123.5%	1.073%
2/11/2021	Citigroup Inc.	33,946	$36K	0.0%	+1,125.0%	0.019%
2/10/2021	Rhumbline Advisers	107,138	$0.11M	0.0%	+129.9%	0.059%
2/10/2021	HighPoint Advisor Group LLC	47,685	$0.13M	0.0%	N/A	0.026%
2/10/2021	QS Investors LLC	70,300	$74K	0.0%	N/A	0.039%
2/10/2021	Harvey Capital Management Inc.	75,000	$78K	0.0%	+87.5%	0.041%
2/9/2021	Wells Fargo & Company MN	298,020	$0.31M	0.0%	+77.4%	0.164%
2/9/2021	Bank of New York Mellon Corp	427,683	$0.45M	0.0%	+121.6%	0.235%
2/9/2021	ProShare Advisors LLC	39,904	$42K	0.0%	N/A	0.022%
2/8/2021	Alliancebernstein L.P.	90,300	$95K	0.0%	-48.8%	0.050%
2/8/2021	State Board of Administration of Florida Retirement System	53,181	$56K	0.0%	+91.9%	0.029%
2/8/2021	New York State Common Retirement Fund	103,400	$0.11M	0.0%	+132.9%	0.057%
2/5/2021	BlackRock Inc.	11,575,051	$12.15M	0.0%	+112.5%	6.356%
2/4/2021	State of Wisconsin Investment Board	250,400	$0.26M	0.0%	+222.7%	0.138%

Data available starting January 2016

iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel. The company is also developing vaccine candidates, including IBIO-101, an antibody to reduce tumor growth; Endostatin E4 peptide for use in chemotherapy and immunotherapy; Trop-2 for the treatment Trop-2 positive cancers; MUC16, a tumor-associated epitope; anti-EGFRvIII antibody to treat glioblastoma and other cancers; CCR8 protein candidate for treatment of various cancers; PD-1 agonist for the treatment of rheumatoid arthritis and other inflammatory diseases; and IBIO-400 for the treatment of classical swine fever. iBio, Inc. has agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; and a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company's AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.

Today's Range

Now: $1.99

$1.95

$2.15

50 Day Range

MA: $1.77

$1.06

$4.06

52 Week Range

Now: $1.99

Volume

174,341 shs

Average Volume

113,212 shs

Market Capitalization

$6.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of iBio?: iBio's top insider investors include:
Martin Brenner (Insider)
Learn More about top insider investors at iBio.

Gold Mania

From Stansberry Research | Ad

See his free reveal right here.